Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.800
+0.085 (4.96%)
At close: Dec 20, 2024, 4:00 PM
1.780
-0.020 (-1.11%)
After-hours: Dec 20, 2024, 5:52 PM EST
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 47 employees as of December 31, 2023. The number of employees increased by 8 or 20.51% compared to the previous year.
Employees
47
Change (1Y)
8
Growth (1Y)
20.51%
Revenue / Employee
n/a
Profits / Employee
-$909,936
Market Cap
119.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
Editas Medicine | 265 |
TELA Bio | 227 |
Zomedica | 144 |
Tenaya Therapeutics | 140 |
Allakos | 131 |
Cabaletta Bio | 103 |
Lineage Cell Therapeutics | 75 |
MIST News
- 5 weeks ago - Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 3 months ago - Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China - GlobeNewsWire
- 3 months ago - Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors - GlobeNewsWire
- 4 months ago - Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire
- 6 months ago - Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024 - GlobeNewsWire
- 7 months ago - Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 months ago - Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™ - GlobeNewsWire
- 7 months ago - Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - GlobeNewsWire